Evidence map›Paper›PMID 41945290›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026

Impact of anemia prior to catheter ablation for atrial fibrillation on clinical outcomes: a U.S. retrospective cohort analysis.

Ahmed Mazen Amin, Rahmah Sameh Shaheen, Wafaa Shehada, Basel Abdelazeem, Ruby Havistin, John N Catanzaro, Nicholas Y Tan, Justin Z Lee, Abhishek J Deshmukh, Christopher V DeSimone

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ahmed Mazen AminFaculty of Medicine, Mansoura University, Mansoura, Egypt.
Rahmah Sameh ShaheenFaculty of Medicine, Benha University, Benha, Egypt.
Wafaa ShehadaFaculty of Medicine, Islamic University of Gaza, Gaza, Palestine. Wafaashehada.1998@gmail.com.
Basel AbdelazeemDepartment of Cardiology, West Virginia University, Morgantown, WV, USA.
Ruby HavistinDepartment of Cardiology, West Virginia University, Morgantown, WV, USA.
John N CatanzaroNorthwell Cardiovascular Institute, Northwell Health, Hofstra School of Medicine, Hempstead, New York, USA.
Nicholas Y TanDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Justin Z LeeDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Abhishek J DeshmukhDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Christopher V DeSimoneDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) and anemia often coexist and are both associated with increased all-cause mortality. However, the impact of anemia on clinical outcomes in patients with AF undergoing catheter ablation remains unclear.

methodsWe conducted a retrospective analysis using the TriNetX database, covering the period from January 2016 to December 2022. Patients aged 18 years or older with AF undergoing their first catheter ablation were included. We performed a comparative analysis of patients with anemia versus those without. Propensity Score Matching (PSM) (1:1) was employed based on all baseline characteristics. The primary outcome was the recurrence of AF after a three-month blanking period over a three-year follow-up.

resultsWe included 28,064 patients who underwent their first catheter ablation, of whom 18,297 were males, and 9,767 were females. Among them, 2,315 males were anemic, and 1,441 females were anemic. PSM resulted in 2,033 male patients in each cohort and 1,338 female patients in each cohort. In the male group, anemia was significantly associated with a higher risk of AF recurrence (HR: 1.159, 95% CI [1.056, 1.273], p = 0.002), with no significant difference in the female group (HR: 1.104, 95% CI [0.985, 1.238], p = 0.089).

conclusionOur study suggests that anemia was significantly associated with a higher risk of AF recurrence in males, with no significant difference in females. In both males and females, anemia was significantly associated with increased risks of acute heart failure, bleeding, acute kidney injury, hospitalizations, and all-cause mortality.

Indexed as

AblationAnemiaAtrial fibrillationRecurrenceTriNetX

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.